The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...

Filmed in black and white and on a modest budget, Clerks was an indie hit in 1994 and launched a number of careers ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

TAKING two common drugs together could slash your levels of ‘bad’ cholesterol and lower the risk of death from heart attack ...

South Korean study suggests statins could lower the dementia risk in people by helping to control low-density lipoprotein - ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...